Clinical Trial Update: Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating Nab-PTX plus S-1 and Sintilimab as adjuvant therapy for Stage IIIC gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Stage Iiic Gastric Cancer

Drugs mentioned

• Nab-PTX (nab-paclitaxel)
• S-1 (tegafur/gimeracil/oteracil)
• Sintilimab (sintilimab)

Snippet

Sponsor: Ruijin Hospital | Conditions: Stage IIIC Gastric Cancer | Phase 1, Phase 2 | Status: UNKNOWN